Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study

Journal of Urology

Volumn 187, Issue 4, 2012, Pages 1247-1252

  Margel, David ^a   Yap, Stanley A ^a   Lawrentschuk, Nathan ^a   Klotz, Laurence ^b   Haider, Masoom ^a   Hersey, Karen ^a   Finelli, Antonio ^a   Zlotta, Alexandre ^a   Trachtenberg, John ^a   Fleshner, Neil ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

biopsy; diagnosis; magnetic resonance imaging; prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACTIVE SURVEILLANCE; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER RISK; COHORT ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPARAMETRIC ENDORECTAL COIL MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY;

COHORT STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS;

EID: 84858704061     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.11.112     Document Type: Article

References (25)

1. Detailed guide: prostate cancerwhat are the key statistics about prostate cancer? American Cancer Society 2009 http://www.cancer.org/docroot/CRI/content/ CRI-2-4-1X-What-are-the-key-statistics-for-prostate-cancer-36.asp Accessed November 2011
2. A. Jemal, R. Siegel, E. Ward Cancer statistics, 2008 CA Cancer J Clin 58 2008 71
3. M.G. Sanda, R.L. Dunn, J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250
4. C. Warlick, B.J. Trock, P. Landis Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355
5. L. Klotz, L. Zhang, A. Lam Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126
6. NCCN Guidelines® and Clinical Resources Updated Prostate Cancer Guidelines, vs 4.2011. National Comprehensive Cancer Network http://www.nccn.org/professionals/physician-gls/f-guidelines.asp#site Accessed November 2011
7. P. Stattin, E. Holmberg, J.E. Johansson Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study J Natl Cancer Inst 102 2010 950
8. L. Klotz Active surveillance for prostate cancer: patient selection and management Curr Oncol, suppl 2 2010 S11
9. S.R. Bott, M.P. Young, M.J. Kellett Anterior prostate cancer: is it more difficult to diagnose BJU Int 89 2002 886
10. N. Lawrentschuk, M.A. Haider, N. Daljeet 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging BJU Int 105 2010 1231
11. J. Kurhanewicz, D. Vigneron, P. Carroll Multiparametric magnetic resonance imaging in prostate cancer: present and future Curr Opin Urol 18 2008 71
12. J.C. Weinreb, J.D. Blume, F.V. Coakley Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomyresults of ACRIN prospective multi-institutional clinicopathologic study Radiology 251 2009 122
13. M.A. Haider, T.H. van der Kwast, J. Tanguay Combined T2-weighted and diffusion-weighted MRI for localization of prostate cancer AJR Am J Roentgenol 189 2007 323
14. O. Akin, E. Sala, C.S. Moskowitz Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 2006 784
15. J.J. Futterer, S.W. Heijmink, T.W. Scheenen Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging Radiology 241 2006 449
16. J.I. Epstein, P.C. Walsh, M. Carmichael Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
17. A.R. Cabrera, F.V. Coakley, A.C. Westphalen Prostate cancer: is in apparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology 247 2008 444
18. N.J. van As, N.M. de Souza, S.F. Riches A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance Eur Urol 56 2008 981
19. V. Fradet, J. Kurhanewicz, J.E. Cowan Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging Radiology 256 2010 176
20. N.M. deSouza, S.F. Riches, N.J. Vanas Diffusion-weighted magnetic resonance imaging: a potential noninvasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 63 2008 774
21. T. Hambrock, D.M. Somford, C. Hoeks Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen J Urol 183 2009 520
22. L. Lemaitre, P. Puech, E. Poncelet Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings Eur Radiol 19 2009 470
23. G. Ploussard, E. Xylinas, X. Durand Magnetic resonance imaging does not improve the prediction of misclassification of prostate cancer patients eligible for active surveillance when the most stringent selection criteria are based on the saturation biopsy scheme BJU Int 108 2011 513
24. M.G. Neill, A. Toi, G.A. Lockwood Systematic lateral prostate biopsyare the benefits worth the costs? J Urol 179 2008 1321
25. R.K. Nam, R. Saskin, Y. Lee Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy J Urol 183 2010 963